fetal repair
Recently Published Documents


TOTAL DOCUMENTS

34
(FIVE YEARS 2)

H-INDEX

5
(FIVE YEARS 0)

Cells ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 2837
Author(s):  
Edwin S Kulubya ◽  
Kaitlin Clark ◽  
Dake Hao ◽  
Sabrina Lazar ◽  
Arash Ghaffari-Rafi ◽  
...  

Spinal cord injury (SCI) is a devasting condition with no reliable treatment. Spina bifida is the most common cause of congenital SCI. Cell-based therapies using mesenchymal stem/stromal cells (MSCS) have been largely utilized in SCI. Several clinical trials for acquired SCI use adult tissue-derived MSC sources, including bone-marrow, adipose, and umbilical cord tissues. The first stem/stromal cell clinical trial for spina bifida is currently underway (NCT04652908). The trial uses early gestational placental-derived mesenchymal stem/stromal cells (PMSCs) during the fetal repair of myelomeningocele. PMSCs have been shown to exhibit unique neuroprotective, angiogenic, and antioxidant properties, all which are promising applications for SCI. This review will summarize the unique properties and current applications of PMSCs and discuss their therapeutic role for acquired SCI.



Author(s):  
Philippe De Vloo ◽  
Luc Joyeux ◽  
Gregory G. Heuer ◽  
N. Scott Adzick ◽  
Jan Deprest ◽  
...  


2020 ◽  
Vol 26 (6) ◽  
pp. 603-604
Author(s):  
Nalin Gupta
Keyword(s):  


Author(s):  
Smruti K Patel ◽  
Mounira A Habli ◽  
David N McKinney ◽  
Sammy M Tabbah ◽  
Foong-Yen Lim ◽  
...  

Abstract Myelomeningocele (MMC) is the most common open neural tube defect associated with long-term survival. In 2011, The Management of Myelomeningocele Study (MOMS) trial demonstrated that fetal repair for MMC reduced the rate of shunted hydrocephalus and improved developmental, motor, and ambulation outcomes at 30 mo compared to postnatal intervention.1 Recent studies have demonstrated the safety and feasibility of fetoscopic MMC repair as well as reduction in preterm birth, lower risk of uterine dehiscence, and the option of vaginal delivery with this approach compared to open fetal repair.2-4 The patient is a 25-yr-old female, G4 P2, who presented at 20 wk's gestation with ultrasound findings concerning for MMC and Chiari II malformation. These findings were further corroborated with fetal magnetic resonance imaging. After extensive prenatal counseling in a multidisciplinary fashion and discussion regarding risks and benefits of prenatal closure of the MMC, the patient chose to undergo prenatal repair and surgical consent was obtained. At 25 wk's gestation, the patient underwent a fetoscopic multilayer closure with dural patch repair using a standardized, 3-port, carbon dioxide insufflation technique for the intrauterine treatment of MMC without any postoperative complications. The duration of the entire procedure was 275 min. At 36 wk's and 1 d's gestational age, the patient had a spontaneous vaginal delivery, resulting in a healthy male newborn. The surgical site was well healed without complications, and follow-up radiographic imaging was reassuring. This edited, 2-dimensional operative video highlights the key steps of the fetoscopic closure with follow-up postnatal clinical and radiographic outcomes.



2020 ◽  
Vol 44 (6) ◽  
pp. 998-1007
Author(s):  
Susana Calle ◽  
Ramesha Papanna ◽  
Katrina Hughes ◽  
Azin Aein ◽  
Roy Riascos ◽  
...  




2020 ◽  
Vol 40 (6) ◽  
pp. 669-673
Author(s):  
Ahmed A. Nassr ◽  
Betul Y. Furtun ◽  
Magdalena Sanz Cortes ◽  
Hadi Erfani ◽  
William E. Whitehead ◽  
...  


2020 ◽  
Vol 55 (3) ◽  
pp. 475-481 ◽  
Author(s):  
John W. Steele ◽  
Sharon Bayliss ◽  
John Bayliss ◽  
Ying Linda Lin ◽  
Bogdan J. Wlodarczyk ◽  
...  


2020 ◽  
Vol 16 (1) ◽  
pp. 3-9 ◽  
Author(s):  
Douglass B. Clayton ◽  
John C. Thomas ◽  
John W. Brock
Keyword(s):  


Sign in / Sign up

Export Citation Format

Share Document